Table 3.
Survival analyses for the primary outcome in the RA Porto cohort.
| Univariable model | Multivariable model | |||
|---|---|---|---|---|
| HR (95%CI) | p-value | HR (95%CI) | p-value | |
| LVMi (per 1 g/m2) | 1.03 (1.02–1.04) |
<0.001 | 1.03 (1.01–1.04) |
<0.001 |
| LVH | 5.38 (2.65–10.94) |
<0.001 | 4.55 (2.17–9.51) |
<0.001 |
| LAVi (per 1 ml/m2) | 1.03 (1.01–1.06) |
0.004 | 1.02 (0.99–1.04) |
0.21 |
| LAVi > 34 ml/m2 | 2.27 (1.19–4.33) |
0.01 | 1.71 (0.88–3.32) |
0.12 |
| E/e′ (per 1) | 1.08 (1.04–1.13) |
<0.001 | 1.06 (1.002–1.13) |
0.042 |
| E/e′ mean >14 | 3.47 (1.58–7.61) |
0.002 | 2.44 (1.03–5.77) |
0.042 |
Multivariable model included age, sex, body mass index, diabetes, systolic blood pressure, estimated glomerular filtration rate and rheumatoid arthritis duration.
LVMi, left ventricular mass indexed; LVH, left ventricular hypertrophy; LAVi, left atrial volume indexed.